Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report

Published:2020-11-10 Issue:2 Volume:12 Page:259-263
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Takeuchi Eiji¹^ORCID,Okamoto Yuri²,Takahashi Naoki³,Morizumi Shun⁴,Toyoda Yuko²,Kuroda Naoto⁵,Yorita Kenji⁶

Affiliation:

1. Department of Clinical Investigation National Hospital Organization Kochi Hospital Kochi Japan

2. Department of Respiratory Medicine Japanese Red Cross Kochi Hospital Kochi Japan

3. Department of Respiratory Medicine and Rheumatology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan

4. Department of Internal Medicine Japan Agricultural Cooperatives Kochi Hospital Nankoku Japan

5. Medical Office Kobe Kyodo Hospital Kobe Japan

6. Department of Diagnostic Pathology Japanese Red Cross Kochi Hospital Kochi Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13733

Reference20 articles.

1. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

2. Rupture of the aorta due to radiation injury. Report of a case and electron microscopic study;Poon TP;JAMA,1968

3. Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease

4. Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report

5. Drastic Response of Rechallenge of Nivolumab in a Patient with NSCLC Who Progressed on the First Nivolumab Treatment;Hirano S;J Thorac Oncol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic complete response of hepatoid adenocarcinoma of the stomach after chemo-immunotherapy: A rare case report and literature review;Frontiers in Surgery;2023-03-30

2. Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review;Journal of Clinical Medicine;2023-02-24

3. Flexible bronchoscopy for lung cancer diagnosis in patients aged ≥85 years;Geriatrics & Gerontology International;2021-11-16

4. Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report;Thoracic Cancer;2021-10-06

5. Successful treatment of two patients with unresectable lung squamous cell carcinoma with tislelizumab regardless of programmed death-ligand 1 expression: a report of two cases;Anti-Cancer Drugs;2021-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3